Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioceramic Sealer in Primary Molars With Missing Successors
NCT07772986Phase 4Completed
- Start
- Mar 2023
- Primary completion
- Jun 2026
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial in irreversible pulpitis and pulp necrosis. Primary endpoint: Number of participants with clinically successful treatment at 24 months. Started Mar 2023; status: completed.
02
Conditions
irreversible pulpitispulp necrosis
Beyond the preview
Go deeper on NCT07772986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07772986.